Artemisinin Resistance inPlasmodium falciparumMalaria | Zendy

Arjen M. Dondorp | Zendy; François Nosten | Zendy; Poravuth Yi | Zendy; Debashish Das | Zendy; Aung Pyae Phyo | Zendy; Joel Tärning | Zendy; Khin Maung Lwin | Zendy; Frédéric Ariey | Zendy; Warunee Hanpithakpong | Zendy; Sue J. Lee | Zendy; Pascal Ringwald | Zendy; Kamolrat Silamut | Zendy; Mallika Imwong | Zendy; Kesinee Chotivanich | Zendy; Pharath Lim | Zendy; Trent Herdman | Zendy; Sen Sam An | Zendy; Shunmay Yeung | Zendy; Pratap Singhasiva | Zendy; Nicholas Day | Zendy; Niklas Lindegårdh | Zendy; Duong Socheat | Zendy; Nicholas J. White | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Artemisinin Resistance inPlasmodium falciparumMalaria

Author(s) -

Arjen M. Dondorp,

François Nosten,

Poravuth Yi,

Debashish Das,

Aung Pyae Phyo,

Joel Tärning,

Khin Maung Lwin,

Frédéric Ariey,

Warunee Hanpithakpong,

Sue J. Lee,

Pascal Ringwald,

Kamolrat Silamut,

Mallika Imwong,

Kesinee Chotivanich,

Pharath Lim,

Trent Herdman,

Sen Sam An,

Shunmay Yeung,

Pratap Singhasiva,

Nicholas Day,

Niklas Lindegårdh,

Duong Socheat,

Nicholas J. White

Publication year - 2009

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa0808859

Subject(s) - artesunate , mefloquine , artemisinin , plasmodium falciparum , medicine , dihydroartemisinin , malaria , pharmacology , pharmacokinetics , interquartile range , drug resistance , immunology , biology , microbiology and biotechnology

Artemisinin-based combination therapies are the recommended first-line treatments of falciparum malaria in all countries with endemic disease. There are recent concerns that the efficacy of such therapies has declined on the Thai-Cambodian border, historically a site of emerging antimalarial-drug resistance.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research